The infrastructure, logistics and regulation are taking shape, albeit at different rates in different territories, and takeback schemes are being trialled in various industries
Their ability to maintain consistent quality standards, invest in ongoing research initiatives, and respond rapidly to evolving consumer preferences has enabled them to capture and sustain substantial market share
RD Lawrence Lecture 2008: Targeting GLP-1 release as a potential strategy for the therapy of Type 2 diabetes
Peptides sit at the intersection of biological plausibility, clinical promise, and aggressive commercialization, and are often marketed as cutting-edge therapies for everything from muscle repair and longevity to cosmetic enhancement
Food and water were available ad libitum and consumption was monitored continuously
Dose increases for insulin occurred for 80% of cases despite combination therapy and insulin treatment